:

A Prelaj1, V Miskovic2, M Zanitti3

  • 1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan; Nearlab, Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Milano, Italy; ESMO Real World Data and Digital Health Working Group, ESMO, Lugano, Switzerland.

概括

人工智能 (AI) 通过分析各种癌症数据,增强免疫检查点抑制剂 (ICI) 疗效预测. 虽然有希望,但需要前性研究来将AI生物标志物纳入临床实践.